AMR Benchmark homepage

Publication - 21 Jan 2020

More pharma companies join the leaders in 2020, yet progress on AMR is slow

GSK and Entasis lead their groups once again, ahead of Pfizer and Wockhardt which both improved. The top 3 generics manufacturers stand out in stewardship. Yet, the pace of change in 2020 does not match the scale of the AMR challenge.

The AMR Benchmark: independent report on pharma’s response to AMR

The 2020 Antimicrobial Resistance Benchmark compares how pharmaceutical companies are bringing AMR under control. It covers R&D, responsible manufacturing, appropriate access and stewardship.

What leaders say

All endorsements

View our media coverage

Back to top |